Beisiegel U, Weber W, Ihrke G, Herz J, Stanley K K
Medical Clinic, University Hospital Eppendorf, Hamburg.
Nature. 1989 Sep 14;341(6238):162-4. doi: 10.1038/341162a0.
The low-density-lipoprotein (LDL) receptor is a cell-surface protein that plays an important part in the metabolism of cholesterol by mediating the uptake of LDL from plasma into cells. Although LDL particles bind to the LDL receptor through their apolipoprotein B (apo B) and apolipoprotein E (apo E) moieties, other apo E-containing particles, like chylomicron remnants, are not dependent on the LDL receptor for uptake into cells. Chylomicrons formed in the intestinal mucosa during the absorption of the products of digestion, are processed by the peripheral circulation by lipoprotein lipase, which catalyses the breakdown of triglycerides in chylomicrons to free fatty acids and glycerol. The resulting chylomicron remnants, which are cholesterol-rich lipoproteins, are subsequently taken up in the liver. A second distinct protein that binds to apo E-containing lipoproteins, but not to LDL, has been proposed to be the receptor mediating the clearance of chylomicron remnants from the plasma. This protein has a relative molecular mass (Mr) of 56,000 (56K). More recent studies have failed, however, to establish whether this protein is a cell-surface receptor. Here we describe crosslinking experiments in which apo E liposomes were found to bind specifically to the cell surface of hepG2 cells and to human liver membranes. The size and immunological cross-reactivity of the protein to which the liposomes bound was indistinguishable from that of the recently cloned and sequenced LDL-receptor-related protein, LRP. We therefore conclude that the LRP might function as an apo E receptor.
低密度脂蛋白(LDL)受体是一种细胞表面蛋白,通过介导血浆中LDL进入细胞,在胆固醇代谢中起重要作用。尽管LDL颗粒通过其载脂蛋白B(apo B)和载脂蛋白E(apo E)部分与LDL受体结合,但其他含apo E的颗粒,如乳糜微粒残粒,进入细胞并不依赖LDL受体。在消化产物吸收过程中于肠黏膜形成的乳糜微粒,由脂蛋白脂肪酶在外周循环中进行处理,该酶催化乳糜微粒中的甘油三酯分解为游离脂肪酸和甘油。产生的乳糜微粒残粒是富含胆固醇的脂蛋白,随后被肝脏摄取。有人提出另一种与含apo E脂蛋白结合但不与LDL结合的独特蛋白是介导乳糜微粒残粒从血浆中清除的受体。这种蛋白的相对分子质量(Mr)为56,000(56K)。然而,最近的研究未能确定该蛋白是否为细胞表面受体。在此我们描述交联实验,发现apo E脂质体可特异性结合HepG2细胞表面及人肝细胞膜。脂质体所结合蛋白的大小和免疫交叉反应性与最近克隆和测序的LDL受体相关蛋白LRP无法区分。因此我们得出结论,LRP可能作为apo E受体发挥作用。